Process View
Any process that modulates the frequency, rate, or extent of leukocyte chemotaxis.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of leukocyte chemotaxis"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | Human | |
FYN | FYN oncogene related to SRC, FGR, YES | 0.995 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.995 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.986 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.977 | Human | |
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.975 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.970 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.929 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.925 | Rat | |
S100B | S100 calcium binding protein B | 0.909 | Human | |
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.889 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.883 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.880 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.878 | ||
IFNG | interferon, gamma | 0.862 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.855 | Human | |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.852 | ||
S100A1 | S100 calcium binding protein A1 | 0.848 | Human | |
VEGFA | vascular endothelial growth factor A | 0.830 | ||
AXL | AXL receptor tyrosine kinase | 0.828 | ||
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.810 | ||
S100A16 | S100 calcium binding protein A16 | 0.809 | Human | |
CD2 | CD2 molecule | 0.785 | ||
NRP1 | neuropilin 1 | 0.784 | ||
S100A14 | S100 calcium binding protein A14 | 0.776 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.757 | ||
IL8 | interleukin 8 | 0.755 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.736 | ||
FN1 | fibronectin 1 | 0.707 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.691 | Human | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.686 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.684 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.629 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.628 | ||
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.614 | Human Zebrafish | |
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.567 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.559 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.558 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.557 | Human | |
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.551 | ||
ABI2 | abl-interactor 2 | 0.534 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.520 | Human | |
PLAT | plasminogen activator, tissue | 0.515 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.487 | ||
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.484 | ||
COL1A1 | collagen, type I, alpha 1 | 0.463 | ||
S100A6 | S100 calcium binding protein A6 | 0.446 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.424 | ||
IL2RG | interleukin 2 receptor, gamma | 0.411 | ||
IL10 | interleukin 10 | 0.407 | ||
IL2RB | interleukin 2 receptor, beta | 0.401 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.391 | ||
FYB | FYN binding protein | 0.371 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.364 | ||
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.354 | ||
CCR2 | chemokine (C-C motif) receptor 2 | 0.346 | ||
ADAM9 | ADAM metallopeptidase domain 9 | 0.342 | Human | |
CCL11 | chemokine (C-C motif) ligand 11 | 0.321 | Human | |
PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.319 | ||
PLAU | plasminogen activator, urokinase | 0.315 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.298 | ||
IL7R | interleukin 7 receptor | 0.297 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.282 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.274 | Human | |
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.256 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.252 | ||
NCF1 | neutrophil cytosolic factor 1 | 0.250 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.248 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.243 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.234 | ||
COL5A1 | collagen, type V, alpha 1 | 0.231 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.230 | ||
MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.228 | ||
SNX33 | sorting nexin 33 | 0.205 | ||
THBS1 | thrombospondin 1 | 0.205 | Human Mouse | |
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.193 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.191 | ||
APOE | apolipoprotein E | 0.190 | ||
S100A9 | S100 calcium binding protein A9 | 0.188 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.182 | ||
PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.179 | ||
JAM2 | junctional adhesion molecule 2 | 0.170 | Human | |
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.166 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.159 | Human | |
EZR | ezrin | 0.158 | ||
RGS1 | regulator of G-protein signaling 1 | 0.152 | ||
LTBP2 | latent transforming growth factor beta binding protein 2 | 0.152 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.151 | Human | |
IRF4 | interferon regulatory factor 4 | 0.150 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.150 | ||
FPR3 | formyl peptide receptor 3 | 0.146 | Human | |
BCL2A1 | BCL2-related protein A1 | 0.146 | ||
COL4A2 | collagen, type IV, alpha 2 | 0.144 | ||
C2 | complement component 2 | 0.144 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.141 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.141 | ||
COL1A2 | collagen, type I, alpha 2 | 0.140 | ||
COL3A1 | collagen, type III, alpha 1 | 0.137 | ||
TNF | tumor necrosis factor | 0.136 | ||
TSC22D4 | TSC22 domain family, member 4 | 0.134 | ||
LDLR | low density lipoprotein receptor | 0.128 | ||
S100A12 | S100 calcium binding protein A12 | 0.128 | Human | |
PLEK | pleckstrin | 0.125 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.123 | Human | |
HCK | hemopoietic cell kinase | 0.123 | ||
MYD88 | myeloid differentiation primary response gene (88) | 0.121 | ||
CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.121 | ||
COL6A3 | collagen, type VI, alpha 3 | 0.113 | ||
HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.112 | ||
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.111 | ||
CD40LG | CD40 ligand | 0.110 | ||
AQP9 | aquaporin 9 | 0.110 | ||
CLEC7A | C-type lectin domain family 7, member A | 0.109 | ||
CYBB | cytochrome b-245, beta polypeptide | 0.106 | ||
LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.104 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.103 | ||
PRKCSH | protein kinase C substrate 80K-H | 0.103 | ||
FZD1 | frizzled homolog 1 (Drosophila) | 0.102 | ||
S100P | S100 calcium binding protein P | 0.100 | Human | |
P4HB | prolyl 4-hydroxylase, beta polypeptide | 0.098 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.097 | Mouse | |
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.096 | ||
F3 | coagulation factor III (thromboplastin, tissue factor) | 0.096 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.096 | ||
UBD | ubiquitin D | 0.095 | ||
SELE | selectin E | 0.093 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.092 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.092 | ||
CYTIP | cytohesin 1 interacting protein | 0.092 | ||
PGF | placental growth factor | 0.091 | Human | |
CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.090 | ||
WISP1 | WNT1 inducible signaling pathway protein 1 | 0.089 | ||
PRRX1 | paired related homeobox 1 | 0.089 | ||
PDGFC | platelet derived growth factor C | 0.088 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.088 | ||
AREG | amphiregulin | 0.087 | ||
JAM3 | junctional adhesion molecule 3 | 0.087 | ||
UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.086 | ||
SLAMF8 | SLAM family member 8 | 0.085 | ||
RHOC | ras homolog gene family, member C | 0.085 | ||
AGER | advanced glycosylation end product-specific receptor | 0.083 | ||
TLR2 | toll-like receptor 2 | 0.083 | ||
COL6A2 | collagen, type VI, alpha 2 | 0.083 | ||
IDE | insulin-degrading enzyme | 0.082 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.082 | ||
S100A8 | S100 calcium binding protein A8 | 0.082 | ||
SLAMF7 | SLAM family member 7 | 0.082 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.081 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.079 | ||
GEM | GTP binding protein overexpressed in skeletal muscle | 0.079 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.079 | Human | |
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.078 | ||
DPT | dermatopontin | 0.078 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.078 | ||
MAPT | microtubule-associated protein tau | 0.077 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.077 | ||
SH3D19 | SH3 domain containing 19 | 0.077 | ||
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.077 | ||
IL1B | interleukin 1, beta | 0.074 | Rat | |
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.074 | ||
CD69 | CD69 molecule | 0.074 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.071 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.071 | ||
IGFBP3 | insulin-like growth factor binding protein 3 | 0.071 | ||
MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.070 | ||
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.070 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.070 | Human | |
TGFB1 | transforming growth factor, beta 1 | 0.070 | ||
GZMK | granzyme K (granzyme 3; tryptase II) | 0.069 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.069 | ||
GYPC | glycophorin C (Gerbich blood group) | 0.069 | ||
ENG | endoglin | 0.068 | ||
IL1RN | interleukin 1 receptor antagonist | 0.068 | ||
CFB | complement factor B | 0.068 | ||
CD83 | CD83 molecule | 0.067 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.066 | ||
INHBA | inhibin, beta A | 0.066 | ||
GPR171 | G protein-coupled receptor 171 | 0.065 | ||
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.065 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.064 | ||
CENPV | centromere protein V | 0.064 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.064 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.063 | ||
HTRA1 | HtrA serine peptidase 1 | 0.062 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.062 | ||
CH25H | cholesterol 25-hydroxylase | 0.061 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.060 | ||
EMD | emerin | 0.059 | ||
VEGFC | vascular endothelial growth factor C | 0.059 | ||
APOC1 | apolipoprotein C-I | 0.059 | ||
CSF1R | colony stimulating factor 1 receptor | 0.058 | Zebrafish | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.058 | ||
IL21R | interleukin 21 receptor | 0.058 | ||
EDN1 | endothelin 1 | 0.056 | Human Rat | |
FASLG | Fas ligand (TNF superfamily, member 6) | 0.055 | ||
LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.055 | ||
TNC | tenascin C | 0.055 | ||
DLG1 | discs, large homolog 1 (Drosophila) | 0.054 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.054 | ||
ITK | IL2-inducible T-cell kinase | 0.053 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.053 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.053 | ||
ITGB5 | integrin, beta 5 | 0.052 | ||
LAT | linker for activation of T cells | 0.052 | ||
SH3PXD2A | SH3 and PX domains 2A | 0.052 | ||
POSTN | periostin, osteoblast specific factor | 0.051 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.051 | ||
JAG1 | jagged 1 | 0.050 | ||
S100A4 | S100 calcium binding protein A4 | 0.050 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.050 | ||
CD48 | CD48 molecule | 0.049 | ||
DARC | Duffy blood group, chemokine receptor | 0.049 | ||
CFP | complement factor properdin | 0.049 | ||
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.049 | Mouse | |
OSMR | oncostatin M receptor | 0.048 | ||
DCN | decorin | 0.047 | ||
FGA | fibrinogen alpha chain | 0.046 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.046 | ||
ERO1L | ERO1-like (S. cerevisiae) | 0.046 | ||
TLR4 | toll-like receptor 4 | 0.045 | ||
IL1R2 | interleukin 1 receptor, type II | 0.044 | ||
RHOA | ras homolog gene family, member A | 0.044 | ||
LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.044 | ||
ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.043 | ||
IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.043 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.043 | ||
FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.043 | ||
CPD | carboxypeptidase D | 0.043 | ||
TGFB2 | transforming growth factor, beta 2 | 0.043 | ||
SFRP4 | secreted frizzled-related protein 4 | 0.042 | ||
ANGPTL2 | angiopoietin-like 2 | 0.042 | ||
IL1R1 | interleukin 1 receptor, type I | 0.042 | ||
C5AR1 | complement component 5a receptor 1 | 0.042 | Human Mouse | |
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.042 | ||
SELL | selectin L | 0.041 | Rat | |
AOAH | acyloxyacyl hydrolase (neutrophil) | 0.041 | ||
CCR9 | chemokine (C-C motif) receptor 9 | 0.040 | Human | |
PDZK1 | PDZ domain containing 1 | 0.040 | ||
ALB | albumin | 0.040 | ||
AEBP1 | AE binding protein 1 | 0.040 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.039 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.039 | ||
PPIB | peptidylprolyl isomerase B (cyclophilin B) | 0.039 | ||
EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.039 | ||
MXRA5 | matrix-remodelling associated 5 | 0.039 | ||
CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.039 | ||
LRP6 | low density lipoprotein receptor-related protein 6 | 0.038 | ||
SLIT3 | slit homolog 3 (Drosophila) | 0.038 | Human | |
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.038 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.037 | ||
ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.037 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.037 | Human | |
APLNR | apelin receptor | 0.037 | ||
TGFB3 | transforming growth factor, beta 3 | 0.037 | ||
IRF8 | interferon regulatory factor 8 | 0.036 | ||
PRKCQ | protein kinase C, theta | 0.035 | ||
HYOU1 | hypoxia up-regulated 1 | 0.035 | ||
GAS6 | growth arrest-specific 6 | 0.035 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.035 | ||
HLA-DMB | major histocompatibility complex, class II, DM beta | 0.035 | ||
RGL1 | ral guanine nucleotide dissociation stimulator-like 1 | 0.035 | ||
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.035 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.035 | ||
PXN | paxillin | 0.035 | ||
LOXL2 | lysyl oxidase-like 2 | 0.034 | ||
THY1 | Thy-1 cell surface antigen | 0.034 | ||
SLA | Src-like-adaptor | 0.034 | ||
FPR1 | formyl peptide receptor 1 | 0.034 | Human | |
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.034 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.034 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.033 | ||
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.033 | ||
DNM1 | dynamin 1 | 0.033 | ||
MSN | moesin | 0.033 | ||
SRPX | sushi-repeat containing protein, X-linked | 0.033 | ||
CLEC5A | C-type lectin domain family 5, member A | 0.033 | ||
STC2 | stanniocalcin 2 | 0.032 | ||
CFI | complement factor I | 0.032 | ||
LAMB1 | laminin, beta 1 | 0.032 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.032 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.032 | ||
IL2RA | interleukin 2 receptor, alpha | 0.032 | ||
ORM1 | orosomucoid 1 | 0.031 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.031 | ||
FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.031 | ||
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.031 | ||
MMP19 | matrix metallopeptidase 19 | 0.030 | ||
PTPRA | protein tyrosine phosphatase, receptor type, A | 0.030 | ||
GPR183 | G protein-coupled receptor 183 | 0.030 | ||
DCBLD1 | discoidin, CUB and LCCL domain containing 1 | 0.030 | ||
IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.030 | ||
DEFB4A | defensin, beta 4A | 0.030 | ||
JAK1 | Janus kinase 1 | 0.030 | ||
CTGF | connective tissue growth factor | 0.030 | ||
CLIC4 | chloride intracellular channel 4 | 0.030 | ||
INADL | InaD-like (Drosophila) | 0.030 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.030 | ||
KYNU | kynureninase | 0.029 | ||
STX8 | syntaxin 8 | 0.029 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.029 | ||
APP | amyloid beta (A4) precursor protein | 0.029 | ||
IL13 | interleukin 13 | 0.029 | ||
SPP1 | secreted phosphoprotein 1 | 0.029 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.029 | ||
PDCD6IP | programmed cell death 6 interacting protein | 0.028 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.028 | Human | |
SFRP2 | secreted frizzled-related protein 2 | 0.028 | ||
ITGA6 | integrin, alpha 6 | 0.028 | ||
FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.028 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.028 | ||
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.028 | ||
RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.028 | ||
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.028 | ||
IFNGR1 | interferon gamma receptor 1 | 0.028 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.028 | ||
EGFL6 | EGF-like-domain, multiple 6 | 0.027 | ||
RUNX3 | runt-related transcription factor 3 | 0.027 | ||
KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.027 | ||
SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.027 | ||
C4BPA | complement component 4 binding protein, alpha | 0.027 | ||
IL18R1 | interleukin 18 receptor 1 | 0.027 | ||
GREM1 | gremlin 1 | 0.027 | ||
CD163 | CD163 molecule | 0.027 | ||
DNASE1L3 | deoxyribonuclease I-like 3 | 0.026 | ||
LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.026 | ||
CD28 | CD28 molecule | 0.026 | ||
LUM | lumican | 0.026 | ||
CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.026 | Human Rat | |
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.026 | ||
CCR6 | chemokine (C-C motif) receptor 6 | 0.026 | Human | |
ECM1 | extracellular matrix protein 1 | 0.026 | ||
RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.026 | Human | |
ARL4C | ADP-ribosylation factor-like 4C | 0.026 | ||
SPRR2A | small proline-rich protein 2A | 0.026 | ||
NRP2 | neuropilin 2 | 0.026 | ||
IL1F5 | interleukin 1 family, member 5 (delta) | 0.026 | ||
RGS4 | regulator of G-protein signaling 4 | 0.025 | ||
IL4 | interleukin 4 | 0.025 | ||
LAPTM5 | lysosomal protein transmembrane 5 | 0.025 | ||
HP | haptoglobin | 0.025 | ||
DKK3 | dickkopf homolog 3 (Xenopus laevis) | 0.025 | ||
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.025 | ||
IL1A | interleukin 1, alpha | 0.025 | ||
RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 0.025 | ||
VCAN | versican | 0.025 | ||
FAP | fibroblast activation protein, alpha | 0.024 | ||
CD84 | CD84 molecule | 0.024 | ||
ALOX5 | arachidonate 5-lipoxygenase | 0.024 | ||
MSR1 | macrophage scavenger receptor 1 | 0.024 | ||
MFAP4 | microfibrillar-associated protein 4 | 0.024 | ||
COL14A1 | collagen, type XIV, alpha 1 | 0.024 | ||
PLXDC1 | plexin domain containing 1 | 0.024 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.024 | ||
C3 | complement component 3 | 0.024 | Human | |
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.024 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.024 | Human | |
ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.024 | ||
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.024 | ||
CD44 | CD44 molecule (Indian blood group) | 0.024 | ||
IL9 | interleukin 9 | 0.024 | ||
LRRC32 | leucine rich repeat containing 32 | 0.024 | ||
MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 0.024 | ||
CLC | Charcot-Leyden crystal protein | 0.023 | ||
PRKCB | protein kinase C, beta | 0.023 | ||
MYH11 | myosin, heavy chain 11, smooth muscle | 0.023 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.023 | ||
LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.023 | ||
VTN | vitronectin | 0.023 | ||
FLRT2 | fibronectin leucine rich transmembrane protein 2 | 0.023 | ||
KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.023 | ||
CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.023 | Human | |
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.023 | ||
COL16A1 | collagen, type XVI, alpha 1 | 0.023 | ||
MSC | musculin | 0.023 | ||
LAMA4 | laminin, alpha 4 | 0.023 | ||
PRKCDBP | protein kinase C, delta binding protein | 0.023 | ||
P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.022 | ||
BIN2 | bridging integrator 2 | 0.022 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.022 | ||
HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.022 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.022 | ||
SNX9 | sorting nexin 9 | 0.022 | ||
DLC1 | deleted in liver cancer 1 | 0.022 | ||
MYLK | myosin light chain kinase | 0.022 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.022 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.022 | ||
THBS2 | thrombospondin 2 | 0.022 | Human | |
KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.022 | ||
EMP1 | epithelial membrane protein 1 | 0.022 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.022 | ||
FKBP4 | FK506 binding protein 4, 59kDa | 0.022 | ||
PDIA4 | protein disulfide isomerase family A, member 4 | 0.022 | ||
TFEC | transcription factor EC | 0.022 | ||
CALR | calreticulin | 0.022 | ||
ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.022 | ||
GPR18 | G protein-coupled receptor 18 | 0.022 | Human | |
SULF1 | sulfatase 1 | 0.022 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.021 | ||
CAMP | cathelicidin antimicrobial peptide | 0.021 | ||
CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 0.021 | ||
PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.021 | ||
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.021 | ||
GLT8D2 | glycosyltransferase 8 domain containing 2 | 0.021 | ||
ADRB2 | adrenergic, beta-2-, receptor, surface | 0.021 | ||
S100A2 | S100 calcium binding protein A2 | 0.021 | Human | |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.021 | ||
SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.021 | ||
FNDC3B | fibronectin type III domain containing 3B | 0.021 | ||
TREM1 | triggering receptor expressed on myeloid cells 1 | 0.021 | ||
IL11 | interleukin 11 | 0.021 | ||
MGP | matrix Gla protein | 0.021 | ||
NNMT | nicotinamide N-methyltransferase | 0.021 | ||
LNX1 | ligand of numb-protein X 1 | 0.021 | ||
STC1 | stanniocalcin 1 | 0.021 | ||
ADAM17 | ADAM metallopeptidase domain 17 | 0.020 | ||
MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.020 | ||
EVI2B | ecotropic viral integration site 2B | 0.020 | ||
BGN | biglycan | 0.020 | ||
TM4SF1 | transmembrane 4 L six family member 1 | 0.020 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.020 | Human | |
SELPLG | selectin P ligand | 0.020 | ||
PF4 | platelet factor 4 | 0.020 | ||
TAGAP | T-cell activation RhoGTPase activating protein | 0.020 | ||
MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.020 | ||
MAP2 | microtubule-associated protein 2 | 0.020 | ||
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.020 | ||
PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.020 | ||
NID1 | nidogen 1 | 0.020 | ||
FMOD | fibromodulin | 0.020 | ||
PLAC8 | placenta-specific 8 | 0.020 | ||
PDPN | podoplanin | 0.019 | ||
A2M | alpha-2-macroglobulin | 0.019 | Human | |
CD22 | CD22 molecule | 0.019 | ||
ELOVL1 | elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 | 0.019 | ||
CLEC4A | C-type lectin domain family 4, member A | 0.019 | ||
TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.019 | ||
AIM2 | absent in melanoma 2 | 0.019 | ||
PARVA | parvin, alpha | 0.019 | ||
PTPRE | protein tyrosine phosphatase, receptor type, E | 0.019 | ||
COL11A1 | collagen, type XI, alpha 1 | 0.019 | ||
IL4R | interleukin 4 receptor | 0.019 | ||
CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.019 | ||
EDNRB | endothelin receptor type B | 0.019 | ||
C7 | complement component 7 | 0.019 | ||
XCL1 | chemokine (C motif) ligand 1 | 0.019 | ||
CD1B | CD1b molecule | 0.019 | ||
FGB | fibrinogen beta chain | 0.019 | ||
EDNRA | endothelin receptor type A | 0.019 | Rat | |
SAMHD1 | SAM domain and HD domain 1 | 0.019 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.019 | ||
LAMC2 | laminin, gamma 2 | 0.019 | ||
PTHLH | parathyroid hormone-like hormone | 0.018 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.018 | ||
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.018 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.018 | ||
GRAP2 | GRB2-related adaptor protein 2 | 0.018 | ||
DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.018 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.018 | ||
GPR65 | G protein-coupled receptor 65 | 0.018 | ||
IGFBP4 | insulin-like growth factor binding protein 4 | 0.018 | ||
TSC22D1 | TSC22 domain family, member 1 | 0.018 | ||
ADORA3 | adenosine A3 receptor | 0.018 | ||
CLEC10A | C-type lectin domain family 10, member A | 0.018 | ||
IL1RAP | interleukin 1 receptor accessory protein | 0.018 | ||
VSIG4 | V-set and immunoglobulin domain containing 4 | 0.018 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.018 | ||
CMKLR1 | chemokine-like receptor 1 | 0.018 | ||
CLEC4E | C-type lectin domain family 4, member E | 0.018 | ||
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.018 | ||
S100A11 | S100 calcium binding protein A11 | 0.018 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.018 | ||
SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 0.018 | ||
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.018 | ||
RHOH | ras homolog gene family, member H | 0.018 | ||
SPON1 | spondin 1, extracellular matrix protein | 0.018 | ||
WISP2 | WNT1 inducible signaling pathway protein 2 | 0.018 | ||
COL8A1 | collagen, type VIII, alpha 1 | 0.018 | ||
SDS | serine dehydratase | 0.018 | ||
GPR109B | G protein-coupled receptor 109B | 0.018 | ||
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.018 | ||
CCR8 | chemokine (C-C motif) receptor 8 | 0.017 | Human | |
PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.017 | ||
LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.017 | ||
CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.017 | ||
SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 0.017 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.017 | ||
GPR84 | G protein-coupled receptor 84 | 0.017 | ||
ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.017 | ||
FKBP1A | FK506 binding protein 1A, 12kDa | 0.017 | ||
LPAR1 | lysophosphatidic acid receptor 1 | 0.017 | ||
PEA15 | phosphoprotein enriched in astrocytes 15 | 0.017 | ||
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.017 | ||
CD53 | CD53 molecule | 0.017 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.017 | ||
TAGLN | transgelin | 0.017 | ||
LAG3 | lymphocyte-activation gene 3 | 0.017 | ||
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.017 | ||
COL5A2 | collagen, type V, alpha 2 | 0.017 | ||
FFAR2 | free fatty acid receptor 2 | 0.017 | ||
CNGB1 | cyclic nucleotide gated channel beta 1 | 0.017 | ||
KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.017 | ||
CD68 | CD68 molecule | 0.017 | ||
CD1A | CD1a molecule | 0.017 | ||
FILIP1L | filamin A interacting protein 1-like | 0.017 | ||
SKAP2 | src kinase associated phosphoprotein 2 | 0.017 | ||
CANX | calnexin | 0.017 | ||
STK17A | serine/threonine kinase 17a | 0.017 | Human | |
SRCIN1 | SRC kinase signaling inhibitor 1 | 0.017 | ||
RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.017 | ||
TRAF3IP3 | TRAF3 interacting protein 3 | 0.017 | ||
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.016 | ||
NLRP3 | NLR family, pyrin domain containing 3 | 0.016 | ||
RGS16 | regulator of G-protein signaling 16 | 0.016 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.016 | ||
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.016 | ||
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.016 | ||
FNDC1 | fibronectin type III domain containing 1 | 0.016 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.016 | ||
XCL2 | chemokine (C motif) ligand 2 | 0.016 | Human | |
ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 | 0.016 | ||
ARHGAP32 | Rho GTPase activating protein 32 | 0.016 | ||
MMP13 | matrix metallopeptidase 13 (collagenase 3) | 0.016 | ||
ICOS | inducible T-cell co-stimulator | 0.016 | ||
LTF | lactotransferrin | 0.016 | ||
ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.016 | ||
IFNB1 | interferon, beta 1, fibroblast | 0.016 | ||
FCAR | Fc fragment of IgA, receptor for | 0.016 | ||
OLFML3 | olfactomedin-like 3 | 0.016 | ||
IL12RB1 | interleukin 12 receptor, beta 1 | 0.016 | ||
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.016 | ||
ACVRL1 | activin A receptor type II-like 1 | 0.016 | ||
LCN2 | lipocalin 2 | 0.016 | ||
SH2D1A | SH2 domain containing 1A | 0.015 | ||
CSNK1A1L | casein kinase 1, alpha 1-like | 0.015 | ||
CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.015 | Human Rat | |
SOCS3 | suppressor of cytokine signaling 3 | 0.015 | ||
ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0.015 | ||
GANAB | glucosidase, alpha; neutral AB | 0.015 | ||
HAS2 | hyaluronan synthase 2 | 0.015 | ||
IGFBP6 | insulin-like growth factor binding protein 6 | 0.015 | ||
PTGES | prostaglandin E synthase | 0.015 | ||
ADAM10 | ADAM metallopeptidase domain 10 | 0.015 | ||
CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.015 | ||
HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.015 | ||
COTL1 | coactosin-like 1 (Dictyostelium) | 0.015 | ||
PTRF | polymerase I and transcript release factor | 0.015 | ||
PRL | prolactin | 0.015 | ||
LY86 | lymphocyte antigen 86 | 0.015 | ||
SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.015 | ||
LENG8 | leukocyte receptor cluster (LRC) member 8 | 0.015 | ||
CAV2 | caveolin 2 | 0.015 | ||
COL2A1 | collagen, type II, alpha 1 | 0.015 | ||
ADAM12 | ADAM metallopeptidase domain 12 | 0.015 | Human | |
ADAM8 | ADAM metallopeptidase domain 8 | 0.015 | ||
APOBEC3A | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | 0.015 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.015 | ||
GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 | 0.015 | ||
CLDN9 | claudin 9 | 0.015 | ||
EVI2A | ecotropic viral integration site 2A | 0.015 | ||
PPIF | peptidylprolyl isomerase F | 0.015 | ||
ABI3BP | ABI family, member 3 (NESH) binding protein | 0.015 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.015 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.015 | ||
DAPK2 | death-associated protein kinase 2 | 0.015 | ||
MFAP5 | microfibrillar associated protein 5 | 0.015 | ||
ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 0.015 | ||
HCFC1R1 | host cell factor C1 regulator 1 (XPO1 dependent) | 0.015 | ||
IGSF6 | immunoglobulin superfamily, member 6 | 0.015 | ||
FGL2 | fibrinogen-like 2 | 0.014 | ||
GJA1 | gap junction protein, alpha 1, 43kDa | 0.014 | ||
PLA2G2D | phospholipase A2, group IID | 0.014 | ||
TICAM2 | toll-like receptor adaptor molecule 2 | 0.014 | ||
SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.014 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.014 | ||
MRC1 | mannose receptor, C type 1 | 0.014 | ||
RNF13 | ring finger protein 13 | 0.014 | ||
PGLYRP1 | peptidoglycan recognition protein 1 | 0.014 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.014 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.014 | ||
RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.014 | ||
SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.014 | ||
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.014 | ||
IL13RA1 | interleukin 13 receptor, alpha 1 | 0.014 | ||
GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.014 | ||
FGG | fibrinogen gamma chain | 0.014 | ||
CMA1 | chymase 1, mast cell | 0.014 | ||
IL1F9 | interleukin 1 family, member 9 | 0.014 | ||
TREM2 | triggering receptor expressed on myeloid cells 2 | 0.014 | ||
SPARCL1 | SPARC-like 1 (hevin) | 0.014 | ||
CD1E | CD1e molecule | 0.014 | ||
JUP | junction plakoglobin | 0.014 | ||
TBC1D10A | TBC1 domain family, member 10A | 0.014 | ||
ANGPTL4 | angiopoietin-like 4 | 0.014 | ||
ARRB2 | arrestin, beta 2 | 0.014 | ||
ZNF358 | zinc finger protein 358 | 0.014 | ||
ITGBL1 | integrin, beta-like 1 (with EGF-like repeat domains) | 0.014 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.014 | ||
MOXD1 | monooxygenase, DBH-like 1 | 0.014 | ||
MUC13 | mucin 13, cell surface associated | 0.014 | ||
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.014 | ||
CST7 | cystatin F (leukocystatin) | 0.013 | ||
GAS7 | growth arrest-specific 7 | 0.013 | ||
OASL | 2'-5'-oligoadenylate synthetase-like | 0.013 | ||
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.013 | ||
SLIT2 | slit homolog 2 (Drosophila) | 0.013 | ||
EMCN | endomucin | 0.013 | ||
MARCO | macrophage receptor with collagenous structure | 0.013 | ||
CRTAM | cytotoxic and regulatory T cell molecule | 0.013 | ||
CHI3L2 | chitinase 3-like 2 | 0.013 | ||
NKG7 | natural killer cell group 7 sequence | 0.013 | ||
EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.013 | ||
GIMAP4 | GTPase, IMAP family member 4 | 0.013 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.013 | ||
WDYHV1 | WDYHV motif containing 1 | 0.013 | ||
F5 | coagulation factor V (proaccelerin, labile factor) | 0.013 | ||
CCBP2 | chemokine binding protein 2 | 0.013 | Human | |
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.013 | ||
MXRA8 | matrix-remodelling associated 8 | 0.013 | ||
RDX | radixin | 0.013 | ||
KNG1 | kininogen 1 | 0.013 | ||
C4orf14 | chromosome 4 open reading frame 14 | 0.013 | ||
CD160 | CD160 molecule | 0.013 | ||
LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.013 | ||
THBD | thrombomodulin | 0.013 | ||
SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.013 | ||
RNASE6 | ribonuclease, RNase A family, k6 | 0.013 | ||
CAPZB | capping protein (actin filament) muscle Z-line, beta | 0.013 | ||
CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 0.013 | ||
ALPI | alkaline phosphatase, intestinal | 0.013 | ||
XCR1 | chemokine (C motif) receptor 1 | 0.013 | Human | |
PROCR | protein C receptor, endothelial | 0.013 | ||
TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.013 | ||
NOS2 | nitric oxide synthase 2, inducible | 0.013 | ||
SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | 0.013 | ||
CD97 | CD97 molecule | 0.013 | ||
P2RY13 | purinergic receptor P2Y, G-protein coupled, 13 | 0.013 | ||
COL10A1 | collagen, type X, alpha 1 | 0.013 | ||
GSTM5 | glutathione S-transferase mu 5 | 0.013 | ||
GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.013 | ||
CFL1 | cofilin 1 (non-muscle) | 0.013 | ||
MPEG1 | macrophage expressed 1 | 0.013 | ||
AKAP6 | A kinase (PRKA) anchor protein 6 | 0.013 | ||
CDA | cytidine deaminase | 0.013 | ||
PRTN3 | proteinase 3 | 0.013 | ||
LAMB3 | laminin, beta 3 | 0.013 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.013 | ||
IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.013 | ||
PTMA | prothymosin, alpha | 0.013 | ||
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.013 | ||
TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 0.013 | ||
IL33 | interleukin 33 | 0.013 | ||
CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 0.013 | ||
MFSD5 | major facilitator superfamily domain containing 5 | 0.012 | ||
C1S | complement component 1, s subcomponent | 0.012 | ||
PVRIG | poliovirus receptor related immunoglobulin domain containing | 0.012 | ||
CP | ceruloplasmin (ferroxidase) | 0.012 | ||
C16orf57 | chromosome 16 open reading frame 57 | 0.012 | ||
SEC24D | SEC24 family, member D (S. cerevisiae) | 0.012 | ||
SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.012 | ||
PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 0.012 | ||
IL6R | interleukin 6 receptor | 0.012 | ||
PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.012 | ||
LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.012 | ||
CMIP | c-Maf-inducing protein | 0.012 | ||
CTSG | cathepsin G | 0.012 | ||
HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.012 | ||
PPDPF | pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) | 0.012 | ||
FST | follistatin | 0.012 | ||
S100A7 | S100 calcium binding protein A7 | 0.012 | ||
ALOX15 | arachidonate 15-lipoxygenase | 0.012 | ||
CNN1 | calponin 1, basic, smooth muscle | 0.012 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.012 | ||
IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.012 | ||
TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.012 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.012 | ||
NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) | 0.012 | ||
TM7SF4 | transmembrane 7 superfamily member 4 | 0.012 | ||
CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 0.012 | ||
ADAM15 | ADAM metallopeptidase domain 15 | 0.012 | Human | |
PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.012 | ||
FXYD3 | FXYD domain containing ion transport regulator 3 | 0.012 | ||
CD300A | CD300a molecule | 0.012 | ||
RGS19 | regulator of G-protein signaling 19 | 0.012 | ||
BNC2 | basonuclin 2 | 0.012 | ||
NID2 | nidogen 2 (osteonidogen) | 0.012 | ||
RHCG | Rh family, C glycoprotein | 0.012 | ||
UBASH3A | ubiquitin associated and SH3 domain containing A | 0.012 | ||
BMP4 | bone morphogenetic protein 4 | 0.012 | ||
SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.012 | ||
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.012 | ||
TRIP10 | thyroid hormone receptor interactor 10 | 0.012 | ||
PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.012 | ||
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | 0.012 | ||
COL4A5 | collagen, type IV, alpha 5 | 0.012 | ||
ADAM28 | ADAM metallopeptidase domain 28 | 0.012 | Human | |
VGLL3 | vestigial like 3 (Drosophila) | 0.012 | ||
PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.012 | ||
ASPN | asporin | 0.012 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.012 | ||
MAP2K2 | mitogen-activated protein kinase kinase 2 | 0.012 | ||
RNASE1 | ribonuclease, RNase A family, 1 (pancreatic) | 0.012 | ||
CD46 | CD46 molecule, complement regulatory protein | 0.012 | ||
ASGR2 | asialoglycoprotein receptor 2 | 0.012 | ||
BDKRB2 | bradykinin receptor B2 | 0.012 | ||
GIMAP5 | GTPase, IMAP family member 5 | 0.012 | ||
NT5E | 5'-nucleotidase, ecto (CD73) | 0.012 | ||
RAB8B | RAB8B, member RAS oncogene family | 0.012 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.011 | ||
FERMT3 | fermitin family member 3 | 0.011 | ||
PDLIM4 | PDZ and LIM domain 4 | 0.011 | ||
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.011 | ||
STAB1 | stabilin 1 | 0.011 | ||
GULP1 | GULP, engulfment adaptor PTB domain containing 1 | 0.011 | ||
GPSM3 | G-protein signaling modulator 3 | 0.011 | ||
NCKAP1 | NCK-associated protein 1 | 0.011 | ||
NPHP1 | nephronophthisis 1 (juvenile) | 0.011 | ||
LY6D | lymphocyte antigen 6 complex, locus D | 0.011 | ||
CILP | cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | 0.011 | ||
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B | 0.011 | ||
TLR3 | toll-like receptor 3 | 0.011 | ||
CALD1 | caldesmon 1 | 0.011 | ||
SORBS3 | sorbin and SH3 domain containing 3 | 0.011 | ||
RNASE3 | ribonuclease, RNase A family, 3 | 0.011 | ||
CD226 | CD226 molecule | 0.011 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.011 | Human | |
DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 0.011 | ||
SKAP1 | src kinase associated phosphoprotein 1 | 0.011 | ||
DOCK1 | dedicator of cytokinesis 1 | 0.011 | ||
CPNE6 | copine VI (neuronal) | 0.011 | ||
BST1 | bone marrow stromal cell antigen 1 | 0.011 | ||
C13orf15 | chromosome 13 open reading frame 15 | 0.011 | ||
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.011 | ||
PRAF2 | PRA1 domain family, member 2 | 0.011 | ||
APOA2 | apolipoprotein A-II | 0.011 | ||
KRT13 | keratin 13 | 0.011 | ||
ZG16B | zymogen granule protein 16 homolog B (rat) | 0.011 | ||
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 0.011 | ||
TRAM1 | translocation associated membrane protein 1 | 0.011 | ||
PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.011 | ||
CD86 | CD86 molecule | 0.011 | ||
SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 0.011 | ||
TPST1 | tyrosylprotein sulfotransferase 1 | 0.011 | ||
CD80 | CD80 molecule | 0.011 | ||
ADAP2 | ArfGAP with dual PH domains 2 | 0.011 | ||
KIF5A | kinesin family member 5A | 0.011 | ||
PLA1A | phospholipase A1 member A | 0.011 | ||
SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.011 | ||
ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.011 | ||
BDKRB1 | bradykinin receptor B1 | 0.011 | ||
DIO2 | deiodinase, iodothyronine, type II | 0.011 |